Quality of life and health status in sarcoidosis patients

Health-Related Quality of Life

Volumn , Issue , 2009, Pages 119-132

  Gvozdenovic, Branislav S ^a   Mihailovic Vucinic, Violeta ^b   Videnovic Ivanov, Jelica ^b   Zugic, Vladimir ^b   Ilic Dudvarski, Aleksandra ^b   Filipovic, Snezana ^b  

^a AbCRO Inc   (Serbia)

^b CLINICAL CENTER OF SERBIA   (Serbia)

Author keywords

Health status; Quality of life; Sarcoidosis

Indexed keywords

EID: 84895348503     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (33)

1. De Vries, J; Wirnsberger, RM. (2005). Fatigue, quality of life and health status in sarcoidosis. Eur Respir Mon, 32, 92-104.
2. Smith, KW; Avis, NE; Assmann, SF. (1999). Distinguishing between quality of life and health status in quality of life research: a meta-analysis. Qual Life Res, 8, 447-59.
3. Bradley C. (2001). Importance of differentiating health status from quality of life. Lancet, 357, 7-8.
4. De Vries J. Quality of life assessment. In: Vingerhoets AJJM, editor. Assessment in Behavioral Medicine. Hove: Brunner-Routledge, 2001, 353-370.
5. Hunninghake, GW; Costabel, U; Ando, M; et al. (1999). ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders. Sarcoidosis Vasc Diffuse Lung Dis, 16, 149-73.
6. Bauer, MP; Brouwer, PA; Smit, VT; Tamsma, JT. (2007). The challenges of extrapulmonary presentations of sarcoidosis: A case report and review of diagnostic strategies. Eur J Intern Med, 18, 152-4.
7. Gvozdenovic, BS; Mihailovic-Vucinic, V; Ilic-Dudvarski, A; Zugic, V; Judson, MA. (2008). Differences in symptom severity and health status impairment between patients with pulmonary and pulmonary plus extrapulmonary sarcoidosis. Respir Med, 102, 1636-42.
8. Kim, JS; Judson, MA; Donnino, R; Gold, M; Cooper, LT; Prystowsky, EN; Prystowsky S. (2009). Cardiac sarcoidosis. Am Heart J, 157, 9-21.
9. Muller-Quernheim J. (1998). Sarcoidosis: immunopathogenetic concepts and their clinical application. Eur Respir J, 12, 716-38.
10. Wirnsberger, RM; De Vries, J; Breteler, MH; et al. (1998). Evaluation of quality of life in sarcoidosis patients. Respir Med, 92, 750-6.
11. Hoitsma, E; De Vries, J; van Santen-Hoeufft, M; Faber, CG; Drent M. (2003). Impact of pain in a Dutch sarcoidosis patient population. Sarcoidosis Vasc Diffuse Lung Dis, 20, 33-9.
12. Victorson, DE; Cella, D; Judson, MA. (2008). Quality of life evaluation in sarcoidosis: current status and future directions. Curr Opin Pulm Med, 14, 470-7.
13. De Vries, J; Drent M. (2004). Relationship between perceived stress and sarcoidosis in a Dutch patient population. Sarcoidosis Vasc Diffuse Lung Dis, 21, 57-63.
14. Reynolds, HY. (2002). Sarcoidosis: impact of other illnesses on the presentation and management of multiorgan disease. Lung, 180, 281-99.
15. Curtis, JR; Borson S. (2001). Examining the link between sarcoidosis and depression. Am J Respir Crit Care Med, 163, 306-8.
16. Drent, M; Wirnsberger, RM; Breteler, MH; et al. (1998). Quality of life and depressive symptoms in patients suffering from sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis, 15, 59-66.
17. World Health Organization Quality of Life Group. (1995). The World Health Organization quality of life assessment (WHOQOL): position paper from the World Health Organization. Soc Sci Med, 41, 1403-9.
18. De Vries J. Beyond health status: construction and validation of the Dutch WHO Quality of Life Instrument. PhD thesis. Tilburg: Tilburg University, 1996.
19. Sintonen, H; Pekurinen M. A fefteen-dimensional measure of health-related quality of life (15D) and its applications. In: Walker, SR; Rosser R. editors. Quality of life assessment: key issues in 1990s. Dordrecht: Kluwer Academic Publishers, 1993; 185-95.
20. Jones, PW; Quirk, FH; Baveystock, CM; Littlejohns P. A self-complete measure of health status for chronic airflow limitation. The St George′s Respiratory Questionnaire. Am Rev Respir Dis, 1992, 145:1321-7.
21. Sintonen H. The 15D-measure of health-related quality of life: I: reliability, validity and sensitivity of its health state descriptive system: working paper 41. Melbourne, Australia: National Centre for Health Program Evaluation, 1994.
22. Sintonen H. The 15D-measure of health-related quality of life: II: feasibility, reliability and validity of its valuation system: working paper 42. Melbourne, Australia: National Centre for Health Program Evaluation; 1994.
23. Gvozdenovic, B; Milosevic, S; Vukovic, M; Plavsic, S; Tomic V. (2001). "15D" and "MiniAQLQ"-validity of the Serbian version of the questionnaires for measurement of quality of life-use in bronchial asthma. Opsta medicina, 7, 21-36.
24. Wirnsberger, RM; Drent, M; Hekelaar, N; Breteler, MH; Drent, S; Wouters, EF; Dekhuijzen, PN. (1997). Relationship between respiratory muscle function and quality of life in sarcoidosis. Eur Respir J, 10, 1450-5.
25. Cox, CE; Donohue, JF; Brown, CD; Kataria, YP; Judson MA. (2004). Health-related quality of life of persons with sarcoidosis. Chest, 125, 997-1004.
26. Mihailovic-Vucinic, V; Zugic, V; Videnovic-Ivanov J. (2003). New observations on pulmonary function changes in sarcoidosis. Curr Opin Pulm Med, 9, 436-41.
27. Cox, CE; Donohue, JF; Brown, CD; et al. (2003). The Sarcoidosis Health Questionnaire: A new measure of health-related quality of life. Am J Respir Crit Care Med, 168, 323-9.
28. Baydur, A; Alsalek, M; Louie, SG; et al. (2001). Respiratory muscle strength, lung function, and dyspnea in patients with sarcoidosis. Chest, 120, 102-8.
29. De Vries, J; Van Heck, GL; Drent M. (1999). Gender differences in sarcoidosis: symptoms, quality of life, and medical consumption. Women Health, 30, 99-114.
30. Dudvarski Ilic A. Assessment of quality of life of patients with multisystemic sarcoidosis. PhD thesis. Belgrade: Belgrade University, 2008.
31. Drent, M; Wirnsberger, RM; de Vries, J; et al. (1999). Association of fatigue with an acute phase response in sarcoidosis. Eur Respir J, 13, 718-22.
32. Hoitsma, E; Faber, CG; Drent, M; et al. (2004). Neurosarcoidosis: a clinical dilemma. Lancet Neurol, 3, 397-407.
33. Judson, MA; Baughman, RP; Teirstein, AS; et al. (1999). Defining organ involvement in sarcoidosis: the ACCESS proposed instrument. Sarcoidosis, Vasc, Diffuse Lung Dis, 16, 75-86.